Drug Dev
Defining AI and working with pharma, Mind the Byte CEO weighs in
On the sidelines of the recent BIO-Europe Spring partnering meeting in Amsterdam, Alfons Nonell-Canals, CEO of artificial intelligence company Mind the Byte, chats with Scrip about the common misconceptions of AI in drug development. He also highlights how the company, which is based in Barcelona, is working with pharma and biotech partners.